Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · October 28, 2024

Mexiletine vs Lamotrigine in Patients With Non-Dystrophic Myotonias

The Lancet Neurology

 

Additional Info

The Lancet Neurology
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Lancet Neurol 2024 Oct 01;23(10)1004-1012, V Vivekanandam, I Skorupinska, DL Jayaseelan, E Matthews, RJ Barohn, MP McDermott, MG Hanna

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading